Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001178913-12-002234
Filing Date
2012-08-09
Accepted
2012-08-09 15:44:39
Documents
1
Period of Report
2012-08-08

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT zk1211853.html 4  
1 OWNERSHIP DOCUMENT zk1211853.xml 4 3994
  Complete submission text file 0001178913-12-002234.txt   5505
Mailing Address 2 ELZA STREET JERUSALEM L3 93706
Business Address 2 ELZA STREET JERUSALEM L3 93706 011 972-54-7909058
ORAMED PHARMACEUTICALS INC. (Issuer) CIK: 0001176309 (see all company filings)

EIN.: 980376008 | State of Incorp.: NV | Fiscal Year End: 0831
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2 ELZA STREET JERUSALEM L3 93706
Business Address
Kidron Miriam (Reporting) CIK: 0001409232 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50298 | Film No.: 121020258